Screener
Arbutus Biopharma Corporation ABUS Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$5.14M-304% | $169.7M+792% | -$3.76M+70.0% | -$7.74M+60.7% | $2.52M+113% | ||
| $11K0.0% | $11K-96.7% | $11K-96.7% | $11K-96.7% | $11K-96.9% | ||
| $1.63M+88.1% | $1.36M-61.9% | $1.26M-22.7% | $1.26M-41.5% | $864K-72.8% | ||
| -$6.02M+61.8% | -$8.11M+39.4% | -$4.68M+54.6% | -$5.82M+71.9% | -$15.75M-8.6% | ||
| —— | $2.2M-80.6% | —— | —— | $15.61M+58.8% | ||
| $3.15M+595% | $11.62M+317% | $1.64M+15.4% | $844K-52.5% | $453K-98.1% | ||
| —— | $5.7M+664% | -$4.4M-198% | -$15M— | $336K-98.3% |
FAQ
- How much cash does Arbutus Biopharma Corporation generate?
- Arbutus Biopharma Corporation (ABUS) generated -$24.6M in operating cash flow over the trailing twelve months.
- Where does Arbutus Biopharma Corporation's cash flow data come from?
- Every line is extracted from Arbutus Biopharma Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
